Prospects of monoclonal antibodies in COVID-19 treatment: a systematic review [post]

Emeka Ogiji, Casimir Ofor, Uchenna Ezenkwa, Kingsley Ukwaja, Charles Maduba, Obumneme Ezeanosike, Samuel Ghasi, Anthony Mbah, Chigozie Uneke, Elvis Shu
2020 unpublished
We reviewed the types of monoclonal antibodies being repurposed for COVID-19 therapeutics, the clinical outcomes and adverse effects so as to provide evidence the bedside physicians, the health policy-makers and the general public could employ in the COVID-19 management protocol. This systematic review was conducted following the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The Joanna Briggs Institute's critical appraisal checklists for evaluation of the
more » ... aluation of the quality of studies were employed to assess the quality of the different types of primary studies included in the review. Our
doi:10.22541/au.159358932.20317539 fatcat:5iuimgrnlrgl3n4zhnurqaacoi